Dean Y. Li, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 15,900 shares at $20.44 ($326K) on 2021-12-07, disclosed to the SEC on 2021-12-09.
Open-market sale of $326k RXRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.44 | 14,900 | $305K | 93.5% |
| 2 | $21.06 | 1,000 | $21K | 6.5% |
| Total | $20.48 avg | 15,900 | $326K | 100% |
| Filing → |
| MRK | SELL | 2024-02-12 | $1.8M | — | Filing → |
| RXRX | SELL | 2024-01-11 | $779K | — | Filing → |
| RXRX | SELL | 2021-12-09 | $770K | — | Filing → |